Luba Greenwood

Luba Greenwood, J.D., currently serves as the Managing Partner of the Binney Street Capital Venture Fund at the Dana-Farber Cancer Institute, a position held since April 2019. In this role, Luba founded and leads the fund, focusing on investing in and building companies in therapeutics, diagnostics, digital health, and medical devices, including Kojin Tx and NextPoint Therapeutics. Additional roles include Senior Advisor to the CEO at Second Opinion Media and podcast host for the Second Opinion Podcast, as well as Chief Executive Officer and Chair of the Board at Kojin Therapeutics. Luba is also a lecturer in Engineering Sciences at Harvard University, serves on the Board of Directors for Abcam and BenchSci, and holds positions as an investor with NextPoint Therapeutics and a board member for IN8bio. Furthermore, Luba is a Board Director at MassBio and acts as a Medical Advisor for StuffThatWorks.